74462-23-0

Upstream product

• 6959-48-4 3-chloromethylpyridinium chloride 
• 137-07-5 2-amino-benzenethiol 

Downstream Products

• 1105675-83-9 N-[2-(3-pyridylmethylthio)phenyl]cinnamide 
• 1427703-06-7 C₄₈H₄₈Cl₂N₈NiS₄ 
• 1427703-11-4 C₄₈H₄₈N₁₄NiS₄ 
• 1427703-09-0 C₅₀H₄₈N₁₀NiO₂S₄ 
• 74462-57-0 3-(2-Pyrrol-1-yl-benzenesulfonylmethyl)-pyridine 
• 74462-39-8 N-[2-(Pyridin-3-ylmethanesulfonyl)-phenyl]-acetamide 
• 74462-47-8 2-(3-picolilsolfonil)anilina 
• 74462-32-1 N-[2-(Pyridin-3-ylmethylsulfanyl)-phenyl]-acetamide 

Relevant academic research and scientific papers

Nickel(II) complexes with 2-(pyridin-3-ylmethylsulfanyl)phenylamine and halide/pseudohalides: Synthesis, structural characterisation, interaction with CT-DNA and bovine serum albumin, and antibacterial activity

A new series of hexacoordinated octahedral nickel(II) complexes of 2-(pyridin-3-ylmethylsulfanyl)phenylamine (L) formulated as [Ni(L) 4(X)2] (1-4) [where X = Cl- (1); NCO - (2); N3- (3) and

Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors

The severe acute respiratory syndrome (SARS) coronavirus 3CL protease is an attractive target for the development of anti-SARS drugs. In this paper, cinanserin (1) analogs were synthesized and tested for the inhibitory activities against SARS-coronavirus (CoV) 3CL protease by fluorescence resonance energy transfer (FRET) assay. Four analogs show significant activities, especially compound 26 with an IC50 of 1.06 μM.